TELA TELA Bio, Inc.
1.070USD-1.83%Mkt Cap: 48.30M $P/E: —1d ago
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's a…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap48.30M USD
Enterprise Value76.43M USD
Revenue (TTM)79.91M USD
Gross Profit54.34M USD
Net Income (TTM)-38.83M USD
Revenue/Share1.51 USD
Last Price1.070 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees218
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.42
PEG—
EV/EBITDA-2.31
EV/Revenue0.96
P/S0.62
P/B-3.08
EPS (TTM)-0.71
EPS (Forward)-0.45
52W Range
0.501052% of range1.600
52W High1.600 USD
52W Low0.5010 USD
Profitability
Gross Margin67.69%
Oper. Margin-48.12%
EBITDA Margin-41.31%
Profit Margin-48.37%
ROE-615.10%
ROA-47.69%
Growth
Revenue Growth-4.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.22M USD
CapEx (TTM)448.00K USD
FCF Margin-22.17%
FCF Yield-36.67%
Net Debt27.49M USD
Net Debt/EBITDA-0.83
Balance Sheet
Debt/Equity8.90
Current Ratio2.99
Quick Ratio2.20
Book Value/Sh-0.35 USD
Cash/Share0.68 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.083 USD
Upside (mean)+94.7%
Target Range1.000 USD – 3.000 USD
1.000+94.7% to mean3.000
# Analysts6
Ownership
Shares Out.45.14M
Float21.23M
Insiders7.11%
Institutions63.29%
Short Interest
Short Ratio1.8d
Short % Float1.76%
Short % Out.1.22%
Shares Short550.82K
Short (prev mo.)338.49K
Technical
SMA 500.9030 (+18.5%)
SMA 2000.8663 (+23.5%)
Beta1.36
S&P 52W Chg16.45%
Avg Vol (30d)282.49K
Avg Vol (10d)213.18K
Technical Indicators
RSI (14)51.2
MACD0.0779
MACD Signal0.1032
MACD Hist.-0.0253
BB Upper1.448 USD
BB Middle1.118 USD
BB Lower0.7886 USD
BB Width58.98%
ATR (14)0.1170 USD
Vol Ratio (20d)0.68x